ARRS organizers credit record-breaking attendance to program, not setting

Article

Forget the stunning scenery, the friendly locals, and the bustling metropolitan center of Vancouver. Organizers of this year’s American Roentgen Ray Society meeting swear that a huge influx of new registrants is mainly due to the robust educational program -- not the beauty of the host city.

Forget the stunning scenery, the friendly locals, and the bustling metropolitan center of Vancouver. Organizers of this year's American Roentgen Ray Society meeting swear that a huge influx of new registrants is mainly due to the robust educational program - not the beauty of the host city.

Attendance for the April 29 to May 5 meeting is up by 22% compared with last year's event in New Orleans, to 2000 registrants. Even though attendance has been growing consistently in recent years, this increase broke records, according to the organizers. Fairly early on in the registration process, the ARRS-aligned hotels booked up, and it became necessary to suggest alternative accommodations.

"This is significant jump over last year," said ARRS president Dr. Bruce McClennan.

He admits Vancouver is a nice city with a mild climate but insists the main attraction is the educational lineup. For example, 500 people, one-quarter of total registrants, plan to attend the daily categorical course. This year's focus on body MRI has proven popular, as shown by the 30% increase in registration over the 2005 categorical course on cardiopulmonary imaging.

As MRI technology moves to higher field strengths - from 1.5T to 3T -

radiologists face a learning curve, McClennan said. A first-rate international lineup of physicians in the categorical course could help fill the education gap.

In the scientific sessions, hot topics include radiofrequency ablation.

"Minimally invasive therapies have been hot for years," McClennan said. "RF ablation has been out long enough for us to now look at small series of patients and determine where the technique fits in the treatment milieu."

Another sizzling topic in the scientific sessions is reduction of radiation exposure from multislice CT.

"With the proliferation of MSCT, awareness is growing that the radiation dose can be higher than with older scanners. There is a need to raise consciousness and educate radiologists about how to get a high-quality study without excess radiation exposure," McClennan said.

For the first time, the ARRS meeting offers practical, case-based daily sessions in general radiology. These are open to all but proving especially popular with residents preparing to take their medical board exams. Throughout the course, 300 cases will be presented to registrants.

The final day of the meeting will feature a session on new issues in cancer imaging. Interest has grown in developing closer working relationships between radiologists and radiation oncologists, McClennan said. The forum will explore collaborative partnerships.

For more information from the Diagnostic Imaging archives

ARRS meeting blends basics with new research

Practical yet vibrant, ARRS program appeals to young and old alike

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.